ClinConnect ClinConnect Logo
Search / Trial NCT06333301

Translational Initiative to Map Epigenetics in Sleep

Launched by ELYSIUM HEALTH · Mar 26, 2024

Trial Information

Current as of July 01, 2025

Not yet recruiting

Keywords

Sleep Chronotype

ClinConnect Summary

The TIME-ZZZ clinical trial is studying how our sleep patterns, known as chronotypes, relate to depression and biological aging. Essentially, the researchers want to find out if people who are not sleeping in sync with their natural body clocks might be more likely to feel depressed and show signs of aging faster. This research is important because understanding these connections could help improve health and well-being.

To participate in this study, you should be between the ages of 65 and 74 or 29 and 219, and you must have taken a specific INDEX test within the last three months. Additionally, you need to have registered for at least one INDEX kit through the Elysium Health website and be willing to give your consent for participation. The trial is not yet recruiting participants, but if you qualify, you can expect to provide some information and possibly take part in assessments related to your sleep and emotional health. Your involvement could contribute to valuable insights into how our sleep habits impact our overall health as we age.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Has taken an INDEX test within the last 3 months
  • Has registered at least 1 INDEX kit via the Elysium Health website
  • Able and willing to provide digital consent to the RSCF, and the TIME-ZZZ Research Subject Consent Form
  • Exclusion Criteria:
  • Consent to participate not given

About Elysium Health

Elysium Health is a biotechnology company dedicated to advancing health and longevity through the development of innovative supplements and therapies. With a strong emphasis on scientific research and collaboration with leading experts in the fields of biochemistry, genetics, and cellular biology, Elysium Health aims to translate groundbreaking discoveries into practical applications that enhance human health. The company’s clinical trials focus on investigating the efficacy and safety of its products, fostering a deeper understanding of the mechanisms underlying aging and age-related conditions. Elysium Health is committed to improving quality of life and promoting wellness across diverse populations through evidence-based solutions.

Locations

Patients applied

0 patients applied

Trial Officials

Dayle Sampson, PhD

Principal Investigator

Elysium Health

Russell Foster, PhD

Principal Investigator

University of Oxford

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported